SCHEMBL463418

SCHEMBL463418

O=CCC(=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27919654 0.75
SCHEMBL60043 0.72
SCHEMBL483026 0.72 CYP2D6 (0.56)
SCHEMBL9488726 0.71
SCHEMBL28790446 0.71
SCHEMBL28314129 0.71
SCHEMBL9225657 0.71
SCHEMBL31690268 0.71 CA4 (0.33)
SCHEMBL562764 0.71
SCHEMBL29017787 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113144916-A Preparation method and application of three-dimensional network porous membrane 北京航空航天大学 2021-07-23 CN claimed
CN-111939458-A Microneedle patch with ultrathin flexible backing layer and preparation method thereof 四川大学 2020-11-17 CN claimed
CN-104877251-B A kind of environmentally friendly low cigarette leadless polyvinyl chloride electrician pipe and preparation method thereof 杭州鸿雁电器有限公司 2017-06-06 CN claimed
WO-2026106208-A1 METHOD FOR PRODUCING HUMAN RECOMBINANT HYALURONIDASE 주식회사 진켐 2026-05-21 WO disclosed
US-20260034078-A1 XPG INHIBITOR COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER FUND D ANNA DE SOMMER CHAMPALIMAUD E DR CARLOS MONTEZ CHAMPALIMAUD (PT) 2026-02-05 US disclosed
EP-4686475-A1 XPG INHIBITORS FOR USE IN THE TREATMENT OF CANCER FUNDAÇÃO D. ANNA DE SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD - CENTRO DE INVESTIGAÇÃO DA FUNDAÇÃO CHAMPALIMAUD (PT) 2026-02-04 EP disclosed
WO-2025039163-A1 SODIUM ALGINATE LYASE, PREPARATION METHOD THEREFOR AND USE THEREOF 财团法人农业科技研究院 2025-02-27 WO disclosed
EP-4436974-A1 SPIROCYCLIC BICYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION Genentech, Inc. (US) 2024-10-02 EP disclosed
CN-114466849-B N-substituted-3, 4- (fused 5-ring) -5-phenyl-pyrrolidin-2-one compounds as ISOQC and/or inhibitors of QC enzymes 欣尼克免疫有限公司 2024-07-12 CN disclosed
US-20240209353-A1 NADK2 INHIBITION IN CANCER AND FIBROTIC DISORDERS MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2024-06-27 US disclosed
CN-117157112-A Medical silicone pressure sensitive adhesive composition 埃肯有机硅(上海)有限公司 2023-12-01 CN disclosed
EP-1082121-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-14 EP disclosed
WO-2000006529-A1 DIKETOACID-DERIVATIVES AS INHIBITORS OF POLYMERASES ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI S.P.A. (IT) 2000-02-10 WO disclosed
WO-1999062520-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO disclosed
EP-0835883-A1 Process for the preparation of ethylene propylene copolymers with a low content of residual chlorine ENICHEM S.p.A. (IT) 1998-04-15 EP disclosed
EP-0434752-B1 THERMOPHILIC ALGINATE LYASE FROM BACILLUS STEAROTHERMOPHILUS NRRL B-18394 NOVO NORDISK A/S (DK) 1993-08-04 EP disclosed
US-5139945-A For degrading algal cell walls; used as a treatment agent in water cooling systems NOVO INDUSTRI A/S (DK) 1992-08-18 US disclosed
EP-0434752-A1 THERMOPHILIC ALGINATE LYASE FROM BACILLUS STEAROTHERMOPHILUS NRRL B-18394. NOVO NORDISK AS (DK) 1991-07-03 EP disclosed
WO-1990002794-A1 THERMOPHILIC ALGINATE LYASE FROM BACILLUS STEAROTHERMOPHILUS NRRL B-18394 NOVO NORDISK A/S (DK) 1990-03-22 WO disclosed
US-4670109-A ANODIC OXIDATION OF ALPHA-BETA UNSATURATED OXIMES FIRMENICH SA (CH) 1987-06-02 US disclosed